211 related articles for article (PubMed ID: 10791998)
1. Epidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal models.
DeClue JE; Heffelfinger S; Benvenuto G; Ling B; Li S; Rui W; Vass WC; Viskochil D; Ratner N
J Clin Invest; 2000 May; 105(9):1233-41. PubMed ID: 10791998
[TBL] [Abstract][Full Text] [Related]
2. Schwann cell lines derived from malignant peripheral nerve sheath tumors respond abnormally to platelet-derived growth factor-BB.
Dang I; DeVries GH
J Neurosci Res; 2005 Feb; 79(3):318-28. PubMed ID: 15602756
[TBL] [Abstract][Full Text] [Related]
3. The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells.
Mashour GA; Ratner N; Khan GA; Wang HL; Martuza RL; Kurtz A
Oncogene; 2001 Jan; 20(1):97-105. PubMed ID: 11244508
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor signaling pathways are associated with tumorigenesis in the Nf1:p53 mouse tumor model.
Li H; Velasco-Miguel S; Vass WC; Parada LF; DeClue JE
Cancer Res; 2002 Aug; 62(15):4507-13. PubMed ID: 12154062
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor, basic fibroblast growth factor and epithelial growth factor receptor in peripheral nerve sheath tumors of neurofibromatosis type 1.
Friedrich RE; Beer C; Glatzel M; Hagel C
Anticancer Res; 2015 Jan; 35(1):137-44. PubMed ID: 25550544
[TBL] [Abstract][Full Text] [Related]
6. NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
Park HJ; Lee SJ; Sohn YB; Jin HS; Han JH; Kim YB; Yim H; Jeong SY
Int J Oncol; 2013 Feb; 42(2):657-66. PubMed ID: 23292448
[TBL] [Abstract][Full Text] [Related]
7. The activation of the WNT signaling pathway is a Hallmark in neurofibromatosis type 1 tumorigenesis.
Luscan A; Shackleford G; Masliah-Planchon J; Laurendeau I; Ortonne N; Varin J; Lallemand F; Leroy K; Dumaine V; Hivelin M; Borderie D; De Raedt T; Valeyrie-Allanore L; Larousserie F; Terris B; Lantieri L; Vidaud M; Vidaud D; Wolkenstein P; Parfait B; Bièche I; Massaad C; Pasmant E
Clin Cancer Res; 2014 Jan; 20(2):358-71. PubMed ID: 24218515
[TBL] [Abstract][Full Text] [Related]
8. Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.
Friedrich RE; Keiner D; Hagel C
Anticancer Res; 2007; 27(4A):2085-90. PubMed ID: 17649826
[TBL] [Abstract][Full Text] [Related]
9. Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis.
Ling BC; Wu J; Miller SJ; Monk KR; Shamekh R; Rizvi TA; Decourten-Myers G; Vogel KS; DeClue JE; Ratner N
Cancer Cell; 2005 Jan; 7(1):65-75. PubMed ID: 15652750
[TBL] [Abstract][Full Text] [Related]
10. Tumorigenic properties of neurofibromin-deficient Schwann cells in culture and as syngrafts in Nf1 knockout mice.
Wu M; Wallace MR; Muir D
J Neurosci Res; 2005 Nov; 82(3):357-67. PubMed ID: 16180234
[TBL] [Abstract][Full Text] [Related]
11. Neurofibromin Deficiency Causes Epidermal Growth Factor Receptor Upregulation through the Activation of Ras/ERK/SP1 Signaling Pathway in Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheet Tumor.
Park GH; Lee SJ; Lee CG; Kim J; Park E; Jeong SY
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948100
[TBL] [Abstract][Full Text] [Related]
12. In vitro studies of steroid hormones in neurofibromatosis 1 tumors and Schwann cells.
Fishbein L; Zhang X; Fisher LB; Li H; Campbell-Thompson M; Yachnis A; Rubenstein A; Muir D; Wallace MR
Mol Carcinog; 2007 Jul; 46(7):512-23. PubMed ID: 17393410
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of PDGFRA cooperates with loss of NF1 and p53 to accelerate the molecular pathogenesis of malignant peripheral nerve sheath tumors.
Ki DH; He S; Rodig S; Look AT
Oncogene; 2017 Feb; 36(8):1058-1068. PubMed ID: 27477693
[TBL] [Abstract][Full Text] [Related]
14. Translationally controlled tumor protein is a novel biological target for neurofibromatosis type 1-associated tumors.
Kobayashi D; Hirayama M; Komohara Y; Mizuguchi S; Wilson Morifuji M; Ihn H; Takeya M; Kuramochi A; Araki N
J Biol Chem; 2014 Sep; 289(38):26314-26326. PubMed ID: 25092287
[TBL] [Abstract][Full Text] [Related]
15. The Challenge of Cancer Genomics in Rare Nervous System Neoplasms: Malignant Peripheral Nerve Sheath Tumors as a Paradigm for Cross-Species Comparative Oncogenomics.
Carroll SL
Am J Pathol; 2016 Mar; 186(3):464-77. PubMed ID: 26740486
[TBL] [Abstract][Full Text] [Related]
16. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
Barkan B; Starinsky S; Friedman E; Stein R; Kloog Y
Clin Cancer Res; 2006 Sep; 12(18):5533-42. PubMed ID: 17000690
[TBL] [Abstract][Full Text] [Related]
17. NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors.
Perry A; Roth KA; Banerjee R; Fuller CE; Gutmann DH
Am J Pathol; 2001 Jul; 159(1):57-61. PubMed ID: 11438454
[TBL] [Abstract][Full Text] [Related]
18. Spatially- and temporally-controlled postnatal p53 knockdown cooperates with embryonic Schwann cell precursor Nf1 gene loss to promote malignant peripheral nerve sheath tumor formation.
Hirbe AC; Dahiya S; Friedmann-Morvinski D; Verma IM; Clapp DW; Gutmann DH
Oncotarget; 2016 Feb; 7(7):7403-14. PubMed ID: 26859681
[TBL] [Abstract][Full Text] [Related]
19. Brain lipid binding protein in axon-Schwann cell interactions and peripheral nerve tumorigenesis.
Miller SJ; Li H; Rizvi TA; Huang Y; Johansson G; Bowersock J; Sidani A; Vitullo J; Vogel K; Parysek LM; DeClue JE; Ratner N
Mol Cell Biol; 2003 Mar; 23(6):2213-24. PubMed ID: 12612091
[TBL] [Abstract][Full Text] [Related]
20. Neurofibromin specific antibody differentiates malignant peripheral nerve sheath tumors (MPNST) from other spindle cell neoplasms.
Reuss DE; Habel A; Hagenlocher C; Mucha J; Ackermann U; Tessmer C; Meyer J; Capper D; Moldenhauer G; Mautner V; Frappart PO; Schittenhelm J; Hartmann C; Hagel C; Katenkamp K; Petersen I; Mechtersheimer G; von Deimling A
Acta Neuropathol; 2014 Apr; 127(4):565-72. PubMed ID: 24464231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
